Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
TNF receptor 2 protects oligodendrocyte progenitor cells against oxidative stress.
Synaptic plasticity in multiple sclerosis and in experimental autoimmune encephalomyelitis.
Histamine h3 receptor integrates peripheral inflammatory signals in the neurogenic control of immune responses and autoimmune disease susceptibility.
The contribution of optical coherence tomography in neurodegenerative diseases.
Acute-Phase Protein Hemopexin Is a Negative Regulator of Th17 Response and Experimental Autoimmune Encephalomyelitis Development.
Interleukin-7 Receptor Single Nucleotide Polymorphism rs6897932 (C/T) and the Susceptibility to Systemic Lupus Erythematosus.
Immunology for understanding the pathogenesis of multiple sclerosis.
[The CD100 semaphorin expression on peripheral blood T-lymphocytes in patients with relapsing-remitting multiple sclerosis.]
Effects of beta 2 adrenergic agonists on axonal injury and mitochondrial metabolism in experimental autoimmune encephalomyelitis rats.
Newer therapies for multiple sclerosis.
Outcomes of Cognitive-Behavioral Treatment for Insomnia on Insomnia, Depression, and Fatigue for Individuals with Multiple Sclerosis: A Case Series.
Patients with neuromyelitis optica have a more severe disease than patients with relapsingremitting multiple sclerosis, including higher risk of dying of a demyelinating disease.
The role of clinical and instrumented outcome measures in balance control of individuals with multiple sclerosis.
Long-term safety and efficacy of natalizumab in relapsing-remitting multiple sclerosis: impact on quality of life.
Is cervical decompression beneficial in patients with coexistent cervical stenosis and multiple sclerosis?
Multiple sclerosis in Japan appears to be a milder disease compared to the UK.
Development of a cross-cultural item bank for measuring quality of life related to mental health in multiple sclerosis patients.
"History had taken such a large piece out of my life" - Neuroscientist refugees from Hamburg during National Socialism.
Inhibition of phosphoinositide 3-kinase delta attenuates experimental autoimmune encephalomyelitis in mice.
Role of neuroinflammation in neurodegenerative diseases (Review).
Structural Brain Network Characteristics Can Differentiate CIS from Early RRMS.
Aerobic and resistance exercise improve walking speed and endurance in people with multiple sclerosis [synopsis].
The role of neutralizing antibodies to interferon-β as a biomarker of persistent MRI activity in multiple sclerosis: a 7-year observational study.
[Treatment of multiple sclerosis: new approaches to treat case by case].
Thalamo-striato-cortical determinants to fatigue in multiple sclerosis.
Pages
« first
‹ previous
…
650
651
652
653
654
655
656
657
658
…
next ›
last »